ACHE and Alzheimer disease: For instance, treatments approved for AD primarily compensate for the loss of cholinergic neurons and include the use of inhibitors of cholinesterases (ChE), such as acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).